Moreover, Ginsenoside Rh2 has been observed to elevate the expression of the lncRNA STXBP5-AS1, which targets miRNA-4425, resulting in the induction of apoptosis and the inhibition of cell proliferation in breast cancer cells (Park et al., 2021). Here, STXBP5 is linked to breast cancer.